Dyne Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.5% | -22.9% | -8.6% | -58.8% | +9.9% | +16.7% | +112.3% | +2.7% | +13.1% | -9.8% | -99.9% | +98.8% | +2,049.8% | +20.5% | -28.0% | -46.1% | +318.7% | +71.7% | |
| – | +68.6% | -27.3% | +10.1% | -70.1% | +55.2% | +61.6% | +58.7% | -27.3% | +53.6% | -49.0% | -99.5% | +80.9% | +2,265.2% | +9.5% | -30.5% | -51.3% | +409.6% | +70.9% | |
| – | +111.3% | -32.0% | -38.2% | +36.1% | -12.1% | +142.2% | +121.8% | -73.0% | +251.7% | -79.4% | -97.8% | +80.1% | +1,956.1% | -33.2% | -14.3% | -29.3% | +258.0% | +105.2% | |
| – | +80.6% | -29.6% | -27.7% | +17.1% | -22.4% | +140.4% | +124.4% | -68.9% | +215.0% | -79.2% | -98.0% | +80.1% | +2,260.0% | +9.1% | -32.0% | -51.9% | +421.7% | +72.9% | |
| – | -20.2% | -37.6% | +8.5% | -97.4% | +1,700.0% | +288.9% | -35.7% | +48.9% | -4.0% | +32.9% | – | – | – | – | – | – | – | – | |
| – | -7.5% | -23.4% | -14.2% | -52.9% | +77.2% | +79.2% | +14.9% | +187.0% | -25.5% | +0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +1,250.9% | +31.0% | +2,004.8% | -6.2% | – | – | – | |
| – | -1.1% | – | – | – | – | – | – | – | +0.3% | -3.4% | – | – | – | – | – | – | – | – | |
| – | -12.1% | -13.0% | -62.9% | – | – | -60.1% | -75.0% | +277.8% | -62.7% | -34.2% | – | – | – | – | – | – | – | – | |
| – | +11.9% | -18.0% | -8.9% | -58.5% | -32.6% | +51.6% | +166.4% | +5.0% | +27.8% | -10.4% | -99.9% | -81.7% | +357.0% | +424.0% | -6.1% | +36.7% | -16.8% | +249.9% | |
| – | +70.4% | +8.5% | -15.3% | -89.8% | +118.2% | +107.8% | -5.5% | +19.2% | +12.8% | +14.5% | -99.9% | +231.6% | +365.1% | +161.9% | -2.2% | +81.9% | -17.3% | +19.8% | |
| – | +25.5% | +1,160.9% | -81.7% | -97.3% | +625.0% | -55.2% | +138.5% | +167.7% | +142.2% | -47.8% | – | – | – | – | +18.4% | +2.4% | +2.8% | +3.0% | |
| – | +3.8% | -40.3% | -26.0% | -88.8% | +646.7% | +193.8% | -34.3% | +35.2% | +13.7% | +10.5% | -99.9% | +142.5% | +173.9% | +17.2% | +30.5% | +336.1% | -71.4% | +23.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | -35.7% | -5.4% | -59.5% | +125.1% | -11.7% | +36.8% | -3.4% | -30.1% | -6.9% | -100.3% | – | +2,339.2% | +7.5% | -31.5% | -63.8% | +589.9% | +54.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -16.5% | +16.0% | -88.0% | +0.8% | -18.0% | +0.0% | +26.0% | +0.0% | +2.4% | +25.6% | -93.6% | +339.9% | +4.1% | +7.7% | +2.1% | +14.8% | +57.7% | +36.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.